Analyst Ratings for SQZ Biotechnologies (SQZ) [Buys]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
5/25/2022 | Chardan Capital Markets | Geulah Livshits | New Coverage | Buy (N/A) |
17.00 (N/A) |
3.35 (0.44) |
-86.87% | Details |
3/31/2021 | Brookline Capital Markets » Updated 3/21/2022 |
Leah Rush Cann | New Coverage | Buy (N/A) |
42.00 (N/A) |
12.07 (0.44) |
-96.35% | Details |